[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.84, "open": 5.7, "dayLow": 5.41, "dayHigh": 5.79, "regularMarketPreviousClose": 5.84, "regularMarketOpen": 5.7, "regularMarketDayLow": 5.41, "regularMarketDayHigh": 5.79, "payoutRatio": 0.0, "beta": 0.69, "forwardPE": -8.469697, "volume": 4566569, "regularMarketVolume": 4566569, "averageVolume": 5583595, "averageVolume10days": 6101890, "averageDailyVolume10Day": 6101890, "bid": 5.45, "ask": 5.73, "bidSize": 61, "askSize": 61, "marketCap": 1670476160, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 50.811417, "fiftyDayAverage": 4.815, "twoHundredDayAverage": 3.436425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1259478016, "profitMargins": 0.0, "floatShares": 202749166, "sharesOutstanding": 298832913, "sharesShort": 46141939, "sharesShortPriorMonth": 43232762, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.15439999, "heldPercentInsiders": 0.22941999, "heldPercentInstitutions": 0.38695, "shortRatio": 9.96, "shortPercentOfFloat": 0.20040001, "impliedSharesOutstanding": 298832913, "bookValue": 3.405, "priceToBook": 1.6417035, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -165664992, "trailingEps": -0.56, "forwardEps": -0.66, "enterpriseToRevenue": 38.31, "enterpriseToEbitda": -5.767, "52WeekChange": 1.0180504, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 5.59, "targetHighPrice": 17.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.33333, "targetMedianPrice": 8.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 553078016, "totalCashPerShare": 1.851, "ebitda": -218379008, "totalDebt": 142080000, "quickRatio": 9.496, "currentRatio": 11.073, "totalRevenue": 32876000, "debtToEquity": 14.108, "revenuePerShare": 0.111, "returnOnAssets": -0.10955, "returnOnEquity": -0.15642999, "grossProfits": -135880000, "freeCashflow": -207588000, "operatingCashflow": -80840000, "revenueGrowth": 1.333, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -2.90242, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.28082, "regularMarketPrice": 5.59, "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1760745357, "regularMarketTime": 1760731201, "exchange": "NMS", "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 0.182469, "postMarketPrice": 5.6002, "postMarketChange": 0.0102, "regularMarketChange": -0.25, "regularMarketDayRange": "5.41 - 5.79", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5583595, "fiftyTwoWeekLowChange": 3.6990001, "fiftyTwoWeekLowChangePercent": 1.9561079, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -0.9249997, "hasPrePostMarketData": true, "fiftyTwoWeekHighChangePercent": -0.14198, "fiftyTwoWeekChangePercent": 101.805046, "earningsTimestamp": 1762459200, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.66, "epsCurrentYear": -0.6025, "priceEpsCurrentYear": -9.278008, "fiftyDayAverageChange": 0.7750001, "fiftyDayAverageChangePercent": 0.16095537, "twoHundredDayAverageChange": 2.1535752, "twoHundredDayAverageChangePercent": 0.62669057, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]